RetroVirox Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $3M
Latest Deal Amount
  • Investors
  • 2

RetroVirox General Information


Provider of biotechnology services intended to discover new treatment methods for infectious diseases. The company's biotechnology services includes developing immunomodulators and antivirals for infectious diseases like HIV and Lassa Fever virus, enabling healthcare companies to get new treatment methods for infectious and acute diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • 6195 Cornerstone Court East
  • Suite 114
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RetroVirox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2015 $3M Completed Generating Revenue
2. Grant 01-Jan-2013 00.000 Completed Generating Revenue
1. Seed Round 01-Jan-2008 Completed Generating Revenue
To view RetroVirox’s complete valuation and funding history, request access »

RetroVirox Executive Team (1)

Name Title Board Seat Contact Info
Juan Lama Ph.D Founder, President and Chief Scientific Officer
To view RetroVirox’s complete executive team members history, request access »

RetroVirox Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RetroVirox Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view RetroVirox’s complete investors history, request access »